Endosome Signaling Part B

1. Auflage 2013
ISBN: 978-0-12-398481-4
Verlag: Elsevier Science & Techn.
Format: EPUB
Kopierschutz: 6 - ePub Watermark

E-Book, Englisch, Band 535, 518 Seiten

Reihe: Methods in Enzymology

This new volume of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This is the second of two volumes on endosome signaling and includes chapters on such topics as measurement of entry into the endosomal compartment by multi-parametric image analysis, assessment of peptide internalization and endosomal signaling, and VEGF-A in endosomal signaling. - Continues the legacy of this premier serial with quality chapters authored by leaders in the field - Covers endosome signaling - Contains chapters on such topics as measurement of biological effects of endosomal proteolysis of internalized insulin and multi-vesicular endosome biogenesis.

Autoren/Hrsg.

Leseproben

Contributors
Veronica Aran,     Division of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom François Authier,     Service information scientifique et technique (IST) de l’Inserm, Délégation régionale Inserm Paris V, Paris, France Masahiro Azuma,     Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan Tadashi Baba,     Department of Microbiology and Infection Control Science, Juntendo University Graduate School of Medicine, Tokyo, Japan Rachel Barrow,     Centre for Tumour Biology, Barts Cancer Institute – A Cancer Research UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, United Kingdom John J.M. Bergeron,     Department of Medicine, and Department of Cell Biology, McGill University, Montreal, Quebec, Canada Rose Cairns,     Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia Eric C. Chang,     Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA Xue Chen,     Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan, and Department of Dermatology, Peking University People’s Hospital, Beijing, China Helen R. Clark,     Virginia Bioinformatics Institute, and Department of Biochemistry, Virginia Tech, Blacksburg, Virginia, USA Bernard Desbuquois,     Inserm U567, Institut Cochin, CNRSUMR 8104, Université Paris-Descartes, Paris, France Gianni M. Di Guglielmo,     Department of Physiology and Pharmacology, Western University, London, Ontario, Canada Nikolai Engedal,     Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway Carlos Enrich,     Departament de Biologia Cellular, Immunologia i Neurociències, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain Marco Falasca,     Inositide Signalling Group, Centre for Diabetes, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom Gareth W. Fearnley,     Endothelial Cell Biology Unit, School of Molecular & Cellular Biology, University of Leeds, Leeds, United Kingdom Theodore Fotsis,     Laboratory of Biological Chemistry, Medical School, University of Ioannina, and Department of Biomedical Research, Foundation for Research & Technology – Hellas, Institute of Molecular Biology & Biotechnology, University Campus of Ioannina, Ioannina, Greece Jürgen Fritsch,     Institute of Immunology, Christian-Albrechts-University of Kiel, Kiel, Germany Kenji Funami,     Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan Mariona Gelabert-Baldrich,     Departament de Biologia Cellular, Immunologia i Neurociències, IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain Thomas Grewal,     Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia Neil Grimsey,     Department of Pharmacology, School of Medicine, University of California, La Jolla, California, USA Mutsuko Hara,     Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan Michael A. Harrison,     School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom Tristan A. Hayes,     Virginia Bioinformatics Institute, and Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, USA Carina Hellberg,     University of Birmingham, School of Biosciences, Birmingham, United Kingdom Maria Hernandez-Valladares,     Division of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom Keiichi Hiramatsu,     Department of Microbiology and Infection Control Science, Juntendo University Graduate School of Medicine, Tokyo, Japan Monira Hoque,     Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia Lukas A. Huber,     Biocenter, Division of Cell Biology, Innsbruck Medical University, Innsbruck, Austria Shigaku Ikeda,     Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan, and Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan Roshanak Irannejad,     Department of Psychiatry and, Department of Cellular & Molecular Pharmacology, University of California School of Medicine, San Francisco, California, USA Kamil Jastrzebski,     Laboratory of Cell Biology, International Institute of Molecular and Cell Biology, Warsaw, Poland Carine Joffre,     Centre for Tumour Biology, Barts Cancer Institute – A Cancer Research UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, United Kingdom, and UNITE 830 INSERM, Institut Curie Centre de Recherche, Paris Cedex 05, France Shiv D. Kale,     Virginia Bioinformatics Institute, Virginia Tech, Blacksburg, Virginia, USA Seiji Kamijo,     Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan Junko Kawasaki,     Atopy (Allergy) Research Center, and Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan Stéphanie Kermorgant,     Centre for Tumour Biology, Barts Cancer Institute – A Cancer Research UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, London, United Kingdom Hirokazu Kinoshita,     Atopy (Allergy) Research Center, and Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan Eleftherios Kostaras,     Laboratory of Biological Chemistry, Medical School, University of Ioannina, and Department of Biomedical Research, Foundation for Research & Technology – Hellas, Institute of Molecular Biology & Biotechnology, University Campus of Ioannina, Ioannina, Greece Sarah J. Kotowski,     Department of Psychiatry and, Department of Cellular & Molecular Pharmacology, University of California School of Medicine, San Francisco, California, USA Antony M. Latham,     Endothelial Cell Biology Unit, School of Molecular & Cellular Biology, University of Leeds, Leeds, United Kingdom Tuan Anh Le,     Atopy (Allergy) Research Center; Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan, and Department of Dermatology and Allergology, Institute of Clinical Medical and Pharmaceutical Sciences 108, Hanoi, Vietnam Huilan Lin,     Department of Pharmacology, School of Medicine, University of California, La Jolla, California, USA Tania Maffucci,     Inositide Signalling Group, Centre for Diabetes, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom Bénédicte Manoury,     INSERM, Unité 1013, and Université Paris Descartes, Sorbonne Paris Cité, Faculté de médecine, Paris, France Misako...